Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lindegger

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Molecular and Cellular Cardiology|April 18, 2009
Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazineN Lindegger, B M Hagen, A R Marks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)T Bachelot, E Ciruelos, A Schneeweiss, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Molecular and Cellular Cardiology|April 18, 2009
Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazineN Lindegger, B M Hagen, A R Marks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)T Bachelot, E Ciruelos, A Schneeweiss, et al.
Pageof 1